Akin’s Battle with AADC Deficiency
A Rare Condition Affecting Only 130 Worldwide
A wave of online support has emerged for Akin, a one-year-old Thai child diagnosed with Aromatic L-amino acid decarboxylase deficiency (AADC Deficiency), an extremely rare genetic disorder affecting only about 130 people globally. Akin is currently receiving treatment at King Chulalongkorn Memorial Hospital in Bangkok, where his family faces overwhelming medical expenses of up to €3 million (105 million baht) for specialized gene therapy.
The Devastating Impact of AADC Deficiency
AADC Deficiency severely hampers the body’s ability to produce essential neurotransmitters like dopamine, serotonin, and epinephrine. This condition leaves patients with little to no functional motor movement, preventing them from meeting developmental milestones. Children with AADC Deficiency require lifelong care and face a high risk of early death within their first decade of life.
The High Cost of Hope: Gene Therapy
Eladocagene Exuparvovec: A Lifeline with a Hefty Price Tag
The only effective treatment for AADC Deficiency is a gene therapy called Eladocagene exuparvovec, which comes with a staggering cost. Unfortunately, this therapy is not available in Thailand, forcing families to seek treatment abroad. While the first three children diagnosed with AADC Deficiency in Thailand were able to participate in drug trials, Akin has not been as fortunate, leaving his family to explore other options.
Negotiations and Fundraising Efforts
King Chulalongkorn Memorial Hospital has negotiated with a pharmaceutical company to reduce the cost of the therapy from €3.6 million to €3 million. Akin’s father, a pharmacist, is tirelessly working to secure the necessary funds. He has turned to fundraising after discovering that drug trial queues in the United States and China are full, with limited slots available.
A Father’s Plea for Help
Time is Running Out for Akin
On January 4, Akin’s father shared an emotional update on the child’s fundraising Facebook page, revealing that Akin is now 15 months old. He emphasized that treatment must begin between 18 and 30 months of age to achieve the best possible outcomes. The family is racing against time to gather the funds needed for Akin’s therapy.
Global Solidarity Through GoFundMe
In a heartwarming show of support, internet users worldwide have rallied behind Akin’s cause, sharing a GoFundMe campaign initiated by the Thai Red Cross Society and the Teach Rare Foundation. This organization was founded by Richard E. Poulin III and Judy Wei after their own daughter was diagnosed with AADC Deficiency. Contributors are encouraged to visit www.gofundme.com to donate and help Akin’s family during this critical time.
The Importance of Rare Disease Awareness
Challenges Faced by Families of Rare Disease Patients
Akin’s story highlights the immense challenges faced by families of children with rare diseases, from exorbitant medical costs to limited treatment options. The lack of accessible therapies in Thailand underscores the need for greater awareness and support for rare genetic disorders.
A Call to Action for Global Support
The outpouring of support for Akin demonstrates the power of community and the importance of collective action in addressing rare diseases. By contributing to Akin’s GoFundMe campaign, individuals can play a vital role in giving this young child a chance at a better life.
